← All trials
NCT02709616
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2016
- Primary completion
- Mar 1, 2018
- Completion date
- Jun 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Guangzhou Medical UniversityLead sponsor
- Guangzhou Medical UniversityOverall official - principal investigator
- Guangzhou Medical UniversityReponsible party - principal investigator
- Beijing Tricision Biotherapeutics IncCollaborator
- Guangzhou Trinomab Biotech Co., Ltd.Collaborator
- Jinan UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.